SLC16A1 and cancer: Furthermore, GPR81 depletion in various cancer cells reduced expression of MCT1 and -4 and limited cancer cell growth, invasiveness, chemotherapy resistance, and Programmed death-ligand 1 (PD-L1) expression [17–23].